Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndromeJohn S Millar, Danielle Duffy, Ramprasad Gadi, et al.The Journal of Clinical Endocrinology and Metabolism|February 16, 2017
A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and PancreatitisMasako Ueda, Richard L Dunbar, Anna Wolska, et al.Journal of Lipid Research|March 19, 2017
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and EJohn S Millar, Michael E Lassman, Tiffany Thomas, et al.The Journal of Clinical Investigation|May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjectsJohn S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.Journal of Lipid Research|February 8, 2017
A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humansMarina Cuchel, Anna C Raper, Donna M Conlon, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer ProteinGissette Reyes-Soffer, John S Millar, Colleen Ngai, et al.The New England Journal of Medicine|May 25, 2017
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular DiseaseFrederick E Dewey, Viktoria Gusarova, Richard L Dunbar, et al.Pageof 4